Listing Conference of FGD for CHB Indications -“Fuganding® TDF” Held in Beijing
Approval of TDF bulk drug and capsules in May, 2017 helps Cosunter become the only enterprise to have the two priority anti-HBV medicines of TDF and ETV, with the most complete production line in the anti-HBV field in China.
“Realizing China Dream: A Visit to Listed Company” - Open Day Activities of Cosunter’s Investors
The “fairness is around us” special investor protection activities jointly sponsored by the China Securities Regulatory Commission Investor Protection Bureau, China Securities Investor Protection Fund Corporation and China Securities Medium and Small Investor Service Center were officially launched in the middle of 2015. On August 28, in cooperation with China Insurance Regulatory Commission Fujian Bureau and Listed Companies Association of Fujian
“The 9th List of Top 50 Enterprises with the Most Investment Value in China” is Revealed
In 2014, the venture capital industry entered a fierce competition and surged forward vigorously, as a result of the frequent release of good news in domestic and international capital markets, strong pickup of American capital market, gradual opening of gates to A-share, grand launch of the new three boards, and registration system injecting huge confidence into the market.